Ionis Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 246.1M | 203.0M | 156.7M | 452.0M | 131.6M | 226.6M | 133.8M | 225.3M |
| Cost of Goods Sold | 3.0M | 8.0M | 2.3M | 4.2M | 1.5M | 3.8M | 1.1M | 4.2M |
| Gross Profit | 243.1M | 195.0M | 154.4M | 447.9M | 130.1M | 222.7M | 132.7M | 221.1M |
| R&D Expenses | 210.2M | 280.0M | 217.8M | 217.5M | 200.8M | 245.5M | 219.8M | 222.1M |
| Operating Expenses | 360.5M | 410.0M | 314.6M | 308.1M | 277.0M | 333.6M | 281.4M | 287.2M |
| Operating Income | -117.4M | -215.0M | -160.2M | 139.8M | -146.9M | -110.8M | -148.7M | -66.1M |
| Other Income / Gains | 25.1M | -13.0M | 31.8M | -16.3M | 38K | 3.8M | 4.6M | -110K |
| Net Income | -92.5M | -229.0M | -128.6M | 123.6M | -146.9M | -104.3M | -140.5M | -66.3M |
| EPS (Diluted) | -0.56 | -1.41 | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.988 | 0.961 | 0.985 | 0.991 | 0.989 | 0.983 | 0.992 | 0.982 |
| General And Administrative Expenses | 0 | 0 | 96.8M | 90.6M | 76.3M | 88.1M | 61.6M | 65.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 150.4M | 130.0M | 96.8M | 90.6M | 76.3M | 88.1M | 61.6M | 65.1M |
| Other Expenses | 0 | 0 | 9K | 22K | -87K | -21K | 38K | 13K |
| Cost And Expenses | 363.5M | 418.0M | 316.9M | 312.2M | 278.5M | 337.4M | 282.5M | 291.3M |
| Interest Income | 25.5M | 24.7M | 23.7M | 24.7M | 24.7M | 28.9M | 26.2M | 25.6M |
| Interest Expense | 22.5M | 22.7M | 22.2M | 22.8M | 22.9M | 22.9M | 22.7M | 22.8M |
| Depreciation And Amortization | 6.8M | 4.82B | 4.5M | 5.5M | 5.4M | 5.3M | 5.5M | 5.6M |
| Ebitda | -68.5M | 4.61B | -103.3M | 150.2M | -120.0M | -80.5M | -117.4M | -37.8M |
| Ebitdaratio | -0.278 | 22.697 | -0.659 | 0.332 | -0.912 | -0.355 | -0.877 | -0.168 |
| Operating Income Ratio | -0.477 | -1.059 | -1.022 | 0.309 | -1.116 | -0.489 | -1.111 | -0.293 |
| Income Before Tax | -92.3M | -228.0M | -128.4M | 123.5M | -146.8M | -107.0M | -144.1M | -66.2M |
| Income Before Tax Ratio | -0.375 | -1.123 | -0.819 | 0.273 | -1.116 | -0.472 | -1.077 | -0.294 |
| Income Tax Expense | 218K | 1.0M | 213K | -20K | 116K | -2.7M | -3.6M | 64K |
| Net Income Ratio | -0.376 | -1.128 | -0.821 | 0.273 | -1.116 | -0.461 | -1.05 | -0.294 |
| Epsdiluted | -0.56 | -1.41 | -0.80 | 0.68 | -0.93 | -0.66 | -0.95 | -0.45 |
| Weighted Average Shs Out | 164.9M | 162.0M | 160.8M | 159.1M | 158.7M | 158.0M | 148.6M | 146.0M |
| Weighted Average Shs Out Dil | 164.9M | 162.0M | 160.8M | 182.3M | 158.7M | 158.0M | 148.6M | 146.0M |